Saro Kobayashi

Mibu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies.

Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies.

Journal: Cephalalgia : an international journal of headache

Published: June 01, 2026

Interictal thermal pain hypersensitivity and central sensitization in migraine patients: a case-control study using quantitative sensory testing.

Interictal thermal pain hypersensitivity and central sensitization in migraine patients: a case-control study using quantitative sensory testing.

Journal: Head & face medicine

Published: January 17, 2026

A Real-World Study of CGRP Monoclonal Antibodies for Migraine: Long-Term Effectiveness and Treatment Adherence.

A Real-World Study of CGRP Monoclonal Antibodies for Migraine: Long-Term Effectiveness and Treatment Adherence.

Journal: European journal of neurology

Published: November 11, 2025

Zilucoplan is effective for ravulizumab-refractory generalized myasthenia gravis with the C5 p.Arg885His variant: a case report.

Zilucoplan is effective for ravulizumab-refractory generalized myasthenia gravis with the C5 p.Arg885His variant: a case report.

Journal: Neuromuscular disorders : NMD

Published: November 09, 2025

A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.

A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.

Journal: Neurological research and practice

Published: April 22, 2025

Managing sleep issues in Parkinson's disease: an up-to-date review.

Managing sleep issues in Parkinson's disease: an up-to-date review.

Journal: Expert review of neurotherapeutics

Published: January 10, 2025

The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine.

The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine.

Journal: The journal of headache and pain

Published: January 07, 2025

Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule.

Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule.

Journal: Journal of the neurological sciences

Published: October 03, 2023

Real-world effectiveness of erenumab in Japanese patients with migraine.

Real-world effectiveness of erenumab in Japanese patients with migraine.

Journal: Heliyon

Published: June 29, 2023

Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?

Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?

Journal: Journal of the neurological sciences

Published: August 16, 2022

Central Sensitization in Migraine: A Narrative Review.

Central Sensitization in Migraine: A Narrative Review.

Journal: Journal of pain research

Published: May 27, 2022

Possible role of neutrophils in astrocyte injury in neuromyelitis optica spectrum disorder.

Possible role of neutrophils in astrocyte injury in neuromyelitis optica spectrum disorder.

Journal: Journal of the neurological sciences

Published: March 09, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026